Stockscreener 앱 받기
6.78
3.28%
-0.23
전일 마감가:
$7.01
열려 있는:
$6.95
하루 거래량:
2.81M
Relative Volume:
0.86
시가총액:
$534.19M
수익:
$65,400
순이익/손실:
$-46.34M
주가수익비율:
-7.3696
EPS:
-0.92
순현금흐름:
$-38.74M
1주 성능:
-11.14%
1개월 성능:
-40.73%
6개월 성능:
-39.08%
1년 성능:
-46.99%
1일 변동 폭
$6.77
$7.0799
1주일 범위
$6.77
$7.59
52주 변동 폭
$5.60
$17.43
CorMedix Inc Stock (CRMD) Company Profile
명칭
CorMedix Inc
전화
908-517-9500
주소
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
CRMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
6.78 | 552.31M | 65,400 | -46.34M | -38.74M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-20 | 업그레이드 | D. Boral Capital | Hold → Buy |
| 2025-06-30 | 다운그레이드 | D. Boral Capital | Buy → Hold |
| 2025-06-30 | 개시 | H.C. Wainwright | Buy |
| 2025-03-07 | 개시 | Leerink Partners | Outperform |
| 2025-01-13 | 개시 | D. Boral Capital | Buy |
| 2024-08-26 | 개시 | Rodman & Renshaw | Buy |
| 2023-08-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-02-17 | 개시 | Needham | Buy |
| 2020-09-29 | 개시 | JMP Securities | Mkt Outperform |
| 2020-09-21 | 개시 | Truist | Buy |
| 2019-12-18 | 개시 | B. Riley FBR | Buy |
| 2019-03-26 | 재확인 | H.C. Wainwright | Buy |
| 2018-12-06 | 개시 | ROTH Capital | Buy |
| 2017-09-25 | 재확인 | H.C. Wainwright | Buy |
| 2017-08-10 | 재확인 | Rodman & Renshaw | Buy |
| 2017-05-05 | 재확인 | Rodman & Renshaw | Buy |
| 2016-11-11 | 재확인 | FBR & Co. | Outperform |
| 2016-03-17 | 재확인 | FBR Capital | Outperform |
| 2016-03-03 | 개시 | FBR Capital | Outperform |
| 2015-11-16 | 재확인 | ROTH Capital | Neutral |
| 2015-10-29 | 재확인 | ROTH Capital | Neutral |
| 2015-05-06 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2014-12-08 | 재확인 | ROTH Capital | Buy |
| 2011-10-03 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
CorMedix Inc 주식(CRMD)의 최신 뉴스
Take Profit: Should I average down on CorMedix Inc stockTake Profit & Safe Capital Growth Stock Tips - baoquankhu1.vn
CorMedix (CRMD) Is Down 11.1% After CEO Becomes Chair And Sets 2026 Revenue TargetHas The Bull Case Changed? - simplywall.st
CorMedix (CRMD) price target decreased by 11.28% to 17.19 - MSN
Breaking Update: Steven Lefkowitz Engages In Options Exercise At Cormedix Realizing $22K - Benzinga
Will DefenCath Continue to Aid CorMedix's Top Line in Q4 Earnings? - Yahoo Finance
Weekly Recap: Is CorMedix Inc benefiting from interest rate changesJuly 2025 WrapUp & Daily Profit Focused Screening - baoquankhu1.vn
Death Cross: Can CorMedix Inc stock deliver 10 annual returnsPortfolio Performance Summary & Daily Chart Pattern Signal Reports - Bộ Nội Vụ
CorMedix (NASDAQ:CRMD) Shareholders Are Still up 63% Over 3 Years Despite Pulling Back 37% in the Past Week - 富途牛牛
CorMedix (CRMD) Valuation After New Leadership Moves And 2026 Revenue Guidance - Sahm
Why Did CRMD Stock Crash 28% Today? - Asianet Newsable
CRMD: 2026 will be a transitional year, with growth driven by new indications and pipeline catalysts - TradingView — Track All Markets
CorMedix stock price target lowered to $15 by Leerink Partners By Investing.com - Investing.com India
CorMedix stock price target lowered to $15 by Leerink Partners - Investing.com Nigeria
CorMedix: The Post-TDAPA Hangover Arrived Early (Rating Downgrade) (NASDAQ:CRMD) - Seeking Alpha
How sustainable is CorMedix Inc. stock dividend payoutWeekly Trading Summary & Precise Buy Zone Identification - Улправда
Asset turnover of CorMedix Inc. – HAM:19KA - TradingView — Track All Markets
CorMedix (CRMD) Is Down 35.4% After Cutting 2026 Revenue Outlook And Reshuffling Leadership - simplywall.st
AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations - The Globe and Mail
CorMedix Faces A Hard Reset As CMS Reimbursement Headwinds Emerge (CRMD) - Seeking Alpha
Are Investors Undervaluing CorMedix (CRMD) Right Now? - Yahoo Finance
CorMedix Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance
How Recent Q3 Updates Are Shaping The CorMedix (CRMD) Investment Story - Yahoo Finance
Why CorMedix (CRMD) Is Down 35.4% After Cutting 2026 Guidance And Revamping Its Leadership Structure - Yahoo Finance
Dow Jumps Over 250 Points; US Initial Jobless Claims Increase - Sahm
CorMedix stock rises after-hours: CEO locks in chairman seat, bigger paycheck and rich severance - MSN
CorMedix Stock Rises After-Hours: CEO Locks In Chairman Seat, Bigger Paycheck And Rich Severance - Stocktwits
CorMedix Inc.Common Stock (NQ: CRMD - FinancialContent
What sentiment indicators say about CorMedix Inc. stockJuly 2025 Levels & Technical Confirmation Alerts - ulpravda.ru
Truist Securities lowers CorMedix stock price target on weaker revenue outlook By Investing.com - Investing.com South Africa
Breakout Move: Will CorMedix Inc. stock maintain growth storyDay Trade & Growth Focused Investment Plans - ulpravda.ru
A Look At CorMedix (CRMD) Valuation After 2026 Guidance Shift And Executive Changes - Yahoo Finance
Why is CorMedix stock crashing today: is it worth buying on the dip? - CryptoRank
Truist Securities lowers CorMedix stock price target on weaker revenue outlook - Investing.com Australia
CorMedix Therapeutics Appoints Joseph Todisco as Chairman, Extends CEO Contract - citybiz
CorMedix shares fall as 2026 revenue outlook disappoints (update) - MSN
Cormedix: Market Overreaction to 2026 Guidance Creates Undervalued Buy Opportunity - TipRanks
Alibaba, Costco among market cap stock movers on Thursday - Investing.com
Why CorMedix stock crashed today and is it worth buying on the dip? - Invezz
Is CorMedix Inc. stock a top pick in earnings seasonJuly 2025 Analyst Calls & Stock Portfolio Risk Management - ulpravda.ru
CorMedix price target lowered to $16 from $20 at Truist - TipRanks
Will CorMedix Inc. stock maintain growth storyQuarterly Trade Report & Smart Money Movement Alerts - ulpravda.ru
CorMedix Inc. Stock (CRMD) Opinions on 2026 Revenue Guidance - Quiver Quantitative
ELVN Stock Shot Up 60% Today – What’s Driving The Rally? - Stocktwits
Is CorMedix Inc. (19KA) stock resilient in recession scenariosLong Setup & Safe Capital Investment Plans - ulpravda.ru
CorMedix shares slip after unveiling lower revenue outlook for 2026 - MSN
GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug - The Globe and Mail
CEO Moves: Is CorMedix Inc. (19KA) stock resilient in recession scenariosJuly 2025 Macro Moves & Verified Swing Trading Watchlist - ulpravda.ru
CorMedix Inc. Provides Earnings Guidance for the Year 2026 - MarketScreener
CorMedix sees FY26 revenue $300M-$320M - TipRanks
CorMedix stock falls after issuing 2026 revenue guidance By Investing.com - Investing.com South Africa
CorMedix Inc (CRMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):